Flamel Now Part of Wacky Lawsuit Hijinks (The Motley Fool)
Shareholders try to sue the inflammable pants off Flamel.

Velcera Receives FDA Feedback on Innovative Canine Allergy Product (Marketwire via Yahoo! Finance)
Velcera, Inc., a specialty pharmaceutical company focused on pet health, announced today that the Center for Veterinary Medicine of the Food and Drug Administration issued early feedback regarding the potential development path of Promist(TM)-VEL-502 as a treatment for the clinical signs of canine allergy.

NCPA President Steve Giroux's Testimony At FDA Behind The Counter Hearing (Medical News Today)
The following is the prepared testimony of NCPA president Steve Giroux before the public meeting of Food and Drug Administration (FDA) regarding behind the counter availability of certain drugs. "Hello, I am Steve Giroux, President of the National Community Pharmacists Association (NCPA) and a pharmacist from Middleport, New York. [click link for full article]